Pillows Can Contain Harmful Fungi

A recent study, reported by the BBC, shows the average pillow is home to a host of potentially-harmful fungi. A University of Manchester team found up to 16 types of fungi in pillows they analysed, the British Allergy journal reported. They said feather pillows had fewer species than synthetic versions, particularly in the case of a fungus which exacerbates asthma. Experts advise disinfecting pillows but say fungi occur in most environments.



The microscopic fungus Aspergillus fumigatus was particularly evident in synthetic pillows. This fungus commonly invades the lungs and sinuses and can worsen asthma. It is also known to cause infection in leukemia and bone marrow transplant patients.



Lead researcher Professor Ashley Woodcock said the findings showed there was a "miniature ecosystem" operating inside pillows. He added: "Since people spend a third of their life sleeping and breathing close to a potentially large and varied source of fungi, these findings certainly have important implications for patients with respiratory disease - especially asthma and sinusitis."

Blog Category: 

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap